Abstract
Hypoxia is involved in the development of chronic inflammatory processes. Under hypoxic conditions HIF1A, VEGF and VEGFR2 are expressed and mediate the course of the resultant disease. The aim of the present study was to define the associations between tSNPs in these genes and COPD susceptibility and progression in a Spanish cohort. The T alleles in rs3025020 and rs833070 SNPs (VEGFA gene) were less frequent in the group of COPD cases and were associated with a lower risk of developing the disease (OR = 0.60; 95% CI = 0. 39–0.93; p = 0.023 and OR = 0.60; 95% CI = 0.38–0.96; p = 0.034, respectively) under a dominant model of inheritance. The haplotype in which both SNPs presented the T allele confirmed the association found (OR = 0.02; 95% CI = 0.00 to 0.66; p = 0.03). Moreover, patients with COPD carrying the T allele in homozygosis in rs3025020 SNP showed higher lung function values and this association remained constant during 3 years of follow-up. In conclusion, T allele in rs833070 and rs3025020 may confer a protective effect to COPD susceptibility in a Spanish population and the association of the SNP rs3025020 with lung function may be suggesting a role for VEGF in the progression of the disease.
Highlights
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death worldwide, mainly caused by tobacco smoking
Our study explores the relationship between Single Nucleotide Polymorphisms (SNPs) in the genes HIF1A, VEGFA and VEGFR2 with COPD
Our major finding is that we found an association of an haplotype containing SNPs rs3025020 and rs833070 in the VEGFA gene with the susceptibility to disease, and an association of SNP rs3025020 with the progression of COPD
Summary
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death worldwide, mainly caused by tobacco smoking. As the disease progresses, the risk of alveolar hypoxia and consequent hypoxemia increase. The principal contributor to hypoxemia in COPD patients is ventilation/perfusion (V/Q) mismatch resulting from progressive airflow limitation and emphysematous destruction of the pulmonary capillary bed. It seems clear that tissue hypoxia is a key player in many of the processes and extrapulmonary comorbidities that characterize COPD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.